Sanofi, Cathay Capital set up $275m fund to back clinical-stage innovative drugs in China

FILE PHOTO: A logo is seen in front of the entrance at the headquarters French drugmaker Sanofi in Paris October 30, 2014. REUTERS/Christian Hartmann/File Photo

Eudora Wang

04 April, 2025

Edited by: Joymitra Rai

cathay capital clinical stage innovative drugs pharmaceuticals Sanofi Sanofi-Cathay Pharmaceutical Innovation Fund

Printed by Unregistered user on Sun, 27 Jul 2025 03:24:04 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

Sanofi, Cathay Capital set up $275m fund to back clinical-stage innovative drugs in China

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

You may also like

Blackstone buys 60% shares in Japanese drug trial company

AI-driven drug discovery firm Insilico bags $100m in fresh funding

Read more from Greater China

Editor’s Take: The Week That Was—July 21-26

Hong Kong IPO boom triggers price war among banks

Sanofi, Cathay Capital set up $275m fund to back clinical-stage innovative drugs in China

Register now to enjoy 3 free articles per month, or log in to continue reading.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

You may also like

Blackstone buys 60% shares in Japanese drug trial company

AI-driven drug discovery firm Insilico bags $100m in fresh funding

Read more from Greater China

Editor’s Take: The Week That Was—July 21-26

Hong Kong IPO boom triggers price war among banks

Register now to enjoy 3 free articles per month,
or log in to continue reading.